Sanja Selak, PhD
Founder and CEO
After more than 20 years of experience in immunology, serology, and antigen discovery, Sanja now strives to advance vaccine discovery and immune therapy development. Previously she was Head of Department of Serology and Immune Assays at Intercell AG, where she distinguished herself for accurately predicting the success of various vaccine candidates in clinical trials based on sophisticated methods for antigen validation that she designed and developed.
Before moving to industry, Sanja studied and worked at world renowned academic institutes around the globe including the Faculty of Medicine, University of Calgary, Canada, Marine Biological Laboratory (MBL), Woods Hole, MA, USA, the Neurobiology Institute Ramon y Cajal in Madrid, and Neuroscience Institute in Alicante, Spain. She is the author of numerous publications and inventor of several patented products.
For Sanja, science is the highest form of art accomplished by a creative imagination. This approach stems from her music background: Sanja is also a music composer and an accomplished pianist.
Tamás Berke, MD, MSc
Co-Founder and COO
Tamás is a physician, trained in pediatric infectious diseases and molecular virology, and a medical biotechnology professional with over 20 years of scientific and industry experience, including project management during all stages of pre-clinical and clinical vaccine development.
He held various positions, such as Head of Grant and Project Management at Arsanis Biosciences, Pre-clinical R&D Project Coordinator at Intercell, and Project Coordinator of Generics Development at Gedeon Richter. At Arsanis, he was instrumental in rasing 9 Mio EUR in venture capital funds and 10 Mio in public funding, i.e. research grants.
For 8 years, he worked in the US at the Center for Pediatric Research of the Eastern Virginia Medical School as research fellow and assistant professor in the field of molecular virology, bioinformatics, molecular epidemiology.
Thomas Fischer, MBA
Thomas has a long track record working in the life science industry. He held CEO and CFO positions in EUCODIS Bioscience, an industrial enzyme-developing company, he also co-founded AUSTRIANOVA, a clinical stage biopharmaceutical company, where he held the position of CFO. Thomas also held executive and supervisory positions at AVENTIS CropScience and NYCOMED Pharma Group.
Thomas started his entrepreneurial career in 1986, in parallel to studying for his MBA at the Vienna University of Economics and Business. He founded his first start-up in Slovakia, followed by co-founding a company group specialized in fast moving consumer goods distribution in central Europe and Russia. Besides building companies, Thomas also enjoys learning about quantum physics, hiking and playing tennis.
Martin Steiner, PhD, MBA
Head of Business Development
Martin has more than 20 years experience in the pharma and biotechnology industry with particular focus on general management and funding of start-up companies as well as business development and corporate strategy.
Martin obtained a PhD in Microbiology and Genetics from the University of Vienna and an MBA from the University of Michigan. He started his professional career as Manager Business Development at SmithKline Beecham Biologicals. He then founded and led two biotechnology companies as CEO, Apovia AG a vaccine development company and ImVisioN Therapeutics an allergy immunotherapy company, which developed products from bench to clinical proof-of-concept. For these companies he raised more than € 35 million form private and institutional investors in several financing rounds. For the last three years, Martin has been an independent consultant to several biotechnology and medtech companies advising in the fields of business and strategy development as well as fund raising.